Salesforce Trades at 14x FCF as Agentforce ARR Soars 330% to $540M
Salesforce now trades at a 14x free cash flow multiple after shifting focus toward profitability and disciplined operations. Its AI-driven Agentforce product delivered 330% year-over-year ARR growth to $540 million, while RPO climbed 12% y/y, underpinning management's plan for 10% CAGR to $60 billion by FY2030.
1. Strategic Pivot Drives Attractive Valuation
Salesforce’s shift from a growth-at-all-costs model to disciplined, profitability-focused operations has driven its valuation to a discounted 14x free-cash-flow multiple, the lowest in the company’s history. Management has tightened expenditure and redirected resources toward high-margin business lines, resulting in a significant improvement in free cash flow conversion. This strategic pivot has captured investor interest by offering both growth optionality and enhanced capital returns over the medium term.
2. Agentforce Records Explosive Adoption
The company’s AI-driven Agentforce product delivered a 330% year-over-year increase in annual recurring revenue, surpassing $540 million by the end of the most recent quarter. This acceleration reflects strong uptake among sales and service organizations seeking to automate customer interactions and drive productivity. Early deployments in financial services and retail verticals report average efficiency gains of 25%, validating the platform’s ability to generate measurable ROI and reinforcing Salesforce’s leadership in enterprise generative AI applications.
3. Backlog Growth and Ambitious Long-Term Targets
Salesforce closed the latest quarter with total remaining performance obligations up 12% year-over-year, demonstrating healthy demand visibility across its core CRM and platform offerings. Management reiterated its goal of achieving a 10% compound annual revenue growth rate through fiscal 2030 and outlined a plan to reach $60 billion in revenue by that time. This roadmap combines steady expansion of subscription bookings, acceleration in professional services revenues, and periodic upsells of emerging AI modules to existing customers.
4. Healthcare Conference Highlights Agentic Enterprise Vision
At the recent healthcare industry conference, Salesforce President Mark Sullivan showcased the evolution from agent-based tools to full ‘agentic enterprises,’ in which AI agents autonomously coordinate cross-functional workflows. He highlighted pilot programs with leading biopharma firms that have reduced clinical trial cycle times by up to 15% through automated patient recruitment, site selection and regulatory filing support. These early successes underscore the platform’s potential to transform complex, regulated industries and open material new revenue streams.